Literature DB >> 24523347

Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study.

Lianping Ti1, M-J Milloy2, Kate Shannon3, Annick Simo4, Robert S Hogg5, Sylvia Guillemi4, Julio Montaner3, Thomas Kerr3, Evan Wood3.   

Abstract

OBJECTIVE: Studies have demonstrated the central function of plasma HIV-1 RNA viral load (pVL) levels on determining the risk of HIV disease progression and transmission. However, there is limited empirical research on virologic outcomes among sex workers who use illicit drugs (SW-DU).
METHODS: Data were derived from the AIDS Care Cohort to evaluate Exposure to Survival Services, a cohort of HIV-positive illicit drug users. Using generalised estimating equations, we studied the longitudinal relationship between sex work and pVL suppression. We also tested whether adherence to antiretroviral therapy (ART) mediated the relationship between sex work and pVL suppression.
RESULTS: Between May 1996 and May 2012, 587 ART-exposed participants (2224 person-years of observation) were included in the study, among whom 127 (21.6%) reported sex work. In a time-updated multivariate model adjusted for various demographic, socioeconomic and clinical confounders (eg, gender, incarceration, CD4 cell count), SW-DU had an independently reduced odds of pVL suppression compared to non-SW-DU (adjusted OR (AOR)=0.66; 95% CI 0.45 to 0.96). However, adding ART adherence to the multivariate model eliminated this association (p>0.05), suggesting adherence mediated the relationship between sex work and pVL suppression.
CONCLUSIONS: Evidence-based interventions to improve adherence to ART among SW-DU are urgently needed to help produce the maximum HIV treatment and prevention benefit of ART among this highly vulnerable population. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Drug Addiction; Drug Misuse; Epidemiology (Clinical); HIV

Mesh:

Substances:

Year:  2014        PMID: 24523347      PMCID: PMC4102614          DOI: 10.1136/sextrans-2013-051408

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  25 in total

1.  HIV/AIDS in India. Sonagachi sex workers stymie HIV.

Authors:  Jon Cohen
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

2.  Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting.

Authors:  M-J Milloy; Thomas Kerr; David R Bangsberg; Jane Buxton; Surita Parashar; Silvia Guillemi; Julio Montaner; Evan Wood
Journal:  AIDS Patient Care STDS       Date:  2011-11-22       Impact factor: 5.078

3.  Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users.

Authors:  Scott E Hadland; M-J Milloy; Thomas Kerr; Ruth Zhang; Silvia Guillemi; Robert S Hogg; Julio S Montaner; Evan Wood
Journal:  AIDS Patient Care STDS       Date:  2012-03-19       Impact factor: 5.078

4.  Barriers to free antiretroviral treatment access for female sex workers in Chennai, India.

Authors:  Venkatesan Chakrapani; Peter A Newman; Murali Shunmugam; Abraham K Kurian; Robert Dubrow
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

5.  Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users.

Authors:  M J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood
Journal:  J Infect Dis       Date:  2011-05-01       Impact factor: 5.226

6.  Sex worker health: San Francisco style.

Authors:  D Cohan; A Lutnick; P Davidson; C Cloniger; A Herlyn; J Breyer; C Cobaugh; D Wilson; J Klausner
Journal:  Sex Transm Infect       Date:  2006-07-19       Impact factor: 3.519

7.  Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside.

Authors:  Kate Shannon; Vicki Bright; Janice Duddy; Mark W Tyndall
Journal:  J Urban Health       Date:  2005-06-08       Impact factor: 3.671

8.  Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver.

Authors:  Kathleen Nicole Deering; Kate Shannon; Hayley Sinclair; Devi Parsad; Erin Gilbert; Mark W Tyndall
Journal:  AIDS Patient Care STDS       Date:  2009-08       Impact factor: 5.078

9.  Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.

Authors:  Adam Gonzalez; Matthew J Mimiaga; Jared Israel; C Andres Bedoya; Steven A Safren
Journal:  AIDS Behav       Date:  2013-01

10.  Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa.

Authors:  Charlotte Huet; Abdoulaye Ouedraogo; Issouf Konaté; Isidore Traore; François Rouet; Antoinette Kaboré; Anselme Sanon; Philippe Mayaud; Philippe Van de Perre; Nicolas Nagot
Journal:  BMC Public Health       Date:  2011-09-14       Impact factor: 3.295

View more
  17 in total

1.  Hepatitis C and the sex trade.

Authors:  Stephen D Shafran
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Nov-Dec

2.  Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis.

Authors:  Sophie Patterson; Angela Kaida; Paul Nguyen; Sabina Dobrer; Gina Ogilvie; Robert Hogg; Thomas Kerr; Julio Montaner; Evan Wood; M-J Milloy
Journal:  CMAJ Open       Date:  2016-04-28

3.  Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs.

Authors:  Mary Clare Kennedy; Thomas Kerr; Ryan McNeil; Surita Parashar; Julio Montaner; Evan Wood; M-J Milloy
Journal:  AIDS Behav       Date:  2017-03

4.  Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.

Authors:  Mary Clare Kennedy; Thomas H Kerr; Evan Wood; Jeannie A Shoveller; Julio S G Montaner; M-J S Milloy
Journal:  AIDS       Date:  2018-05-15       Impact factor: 4.177

5.  Factors associated with illicit methadone injecting in a Canadian setting.

Authors:  Devin Tucker; M-J Milloy; Kanna Hayashi; Paul Nguyen; Thomas Kerr; Evan Wood
Journal:  Am J Addict       Date:  2015-08-18

6.  Ongoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy.

Authors:  Leslie Lappalainen; Kanna Hayashi; Huiru Dong; M J Milloy; Thomas Kerr; Evan Wood
Journal:  Addiction       Date:  2014-10-16       Impact factor: 6.526

7.  HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs.

Authors:  Tara Beaulieu; Kanna Hayashi; Michael J Milloy; Ekaterina Nosova; Kora DeBeck; Julio Montaner; Thomas Kerr; Lianping Ti
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

8.  Barriers to Viral Suppression Among Female Sex Workers: Role of Structural and Intimate Partner Dynamics.

Authors:  Putu Duff; Shira Goldenberg; Kathleen Deering; Julio Montaner; Paul Nguyen; Sabina Dobrer; Kate Shannon
Journal:  J Acquir Immune Defic Syndr       Date:  2016-09-01       Impact factor: 3.731

9.  Sociodemographic factors affecting viral load suppression among people living with HIV in South Carolina.

Authors:  Mohammad Rifat Haider; Monique J Brown; Sayward Harrison; Xueying Yang; LaDrea Ingram; Amir Bhochhibhoya; Akeen Hamilton; Bankole Olatosi; Xiaoming Li
Journal:  AIDS Care       Date:  2019-12-19

10.  "Todo se trata de a quién conoces": Social Networks and Drug Use Among Female Sex Workers Living with HIV in the Dominican Republic.

Authors:  Erica Felker-Kantor; Caluz Polanco; Martha Perez; Yeycy Donastorg; Katherine Andrinopoulos; Carl Kendall; Deanna Kerrigan; Katherine P Theall
Journal:  AIDS Behav       Date:  2020-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.